Federal Register / Vol. 70, No. 172 / Wednesday, September 7, 2005 / Notices 53185 

signs from terbacil and bromacil 

follows. 

The following clinical signs were 

observed in the terbacil toxicology 

database: Decrease in body weight, 

increase in liver weights, vacuolization 

and hypertrophy of hepatocytes, 

hypertrophy of centrilobular 

hepatocytes in males, decreased 

pituitary weights in males and females, 

increase in thyroid/body weight ratio, 

and elevated alkaline phosphatase. 

The following clinical signs were 

observed in the bromacil toxicology 

database: Decreased body weight, focal 

atrophy of seminiferous tubules 

(testicular abnormalities), 

hydronephrosis, suggestive histological 

evidence for antithyroid activity (cystic 

follicles in the thyroid and enlargement 

of centrilobular cells of the liver), and 

a positive trend in thyroid tumors for 

male rats (basis of C classification for 

carcinogenicity). 

Based on these data, DuPont 

concludes that there is no clear common 

mode of toxicity (thyroid or liver) 

between terbacil and bromacil. With 

both chemicals, there is marginal 

evidence of liver effects (principally 

enlargement of centrilobular cells). 

Enlargement of liver cells is not a 

specific enough effect to be considered 

a common mode of toxicity. The thyroid 

effects observed with bromacil were 

cystic follicles. Terbacil induced an 

increase in relative thyroid weights but 

no increase in absolute thyroid weights. 

An increase in relative weight without 

a corresponding increase in absolute 

weight has very little meaning, 

especially without any supporting 

histological or hormonal evidence. This 

conclusion was based on the marginal 

liver effects noted in the databases, and 

the absence of thyroid effects in the 

terbacil database (with the exception of 

increases in relative thyroid weights). 

DuPont has no information indicating 

that any other chemical has a common 

mode of toxicity with terbacil and, 

therefore concludes that an aggregate 

risk assessment will indicate risks 

resulting only from terbacil. 

E. Safety Determination 

1. U.S. population. EPA has 

determined that the established 

tolerances for terbacil meet the safety 

standards under the FQPA amendments 

to section 408(b)(2)(D) for the general 

population. In reaching this 

determination, EPA has considered 

available information on aggregate 

exposures (both acute and chronic) from 

non-occupational sources, food and 

drinking water, as well as the possibility 

of cumulative effects from terbacil and 

other chemicals with similar 

mechanism of toxicity. 

Since there are no residential or lawn 

uses of terbacil, no dermal or inhalation 

exposure is expected in and around the 

home. 

In assessing acute dietary risk from 

food, the endpoint selected was 

developmental toxicity. Because the 

endpoint of concern is a developmental 

effect, the only sub-population of 

concern is females of child-bearing age 

(i.e., females, 13+ years old). 

The acute risk values were calculated 

by DuPont with an aRfD of 0.125 mg/kg 

bwt/day. The acute dietary exposure (at 

the 95th percentile) for the U.S. 

population was 0.003071 mg/kg bwt/ 

day (2.5% of aRfD). The most sensitive 

subpopulation was children 1-2 years 

old with an acute dietary exposure (at 

the 95th percentile) of 0.015641 mg/kg 

bwt/day (12.5% aRfD). 

The chronic risk values were 

calculated by DuPont with a cRfD of 

0.013 mg/kg bwt/day. The chronic 

dietary exposure for the U.S. population 

was 0.000725 mg/kg bwt/day (5.6% of 

the cRfD). The most sensitive 

subpopulation was children 1-6 years 

old with a chronic dietary exposure of 

0.002991 mg/kg bwt/day (23.0% of the 

cRfD). 

In evaluating the potential for 

cumulative effects, EPA compared 

terbacil with other structurally similar 

substituted uracil compounds, such as 

bromacil and lenacil, and then with 

other compounds producing similar 

effects. A comparison of the available 

toxicological database for terbacil and 

bromacil revealed no clear common 

mode of toxicity for the chemicals. The 

toxicology database for lenacil was not 

considered because there are currently 

no registered uses of lenacil. Based on 

the available data, the Agency has 

determined that there is no clear 

common mode of toxicity between 

terbacil and bromacil. 

2. Infants and children. EPA has 

determined that the established 

tolerances for terbacil meet the safety 

standard under the FQPA amendment to 

section 408(b)(2)(C) for infants and 

children. The safety determination for 

infants and children considers the 

factors noted above for the general 

population, but also takes into account 

the possibility of increased dietary 

exposure due to the specific 

consumption patterns of infants and 

children, as well as the possibility of 

increased susceptibility to the toxic 

effects of terbacil residues in this 

population subgroup. 

In determining whether or not infants 

and children are particularly susceptible 

to toxic effects from terbacil residues, 

EPA considered the completeness of the 

database for developmental and 

reproductive effects, the nature of the 

effects observed, and other information. 

Based on current data requirements, 

terbacil has a complete database for 

developmental and reproductive 

toxicity. Because the developmental 

NOAELs were the same as those for 

maternal toxicity, and the NOAEL for 

systemic (parental) toxicity was higher 

than the NOAEL for reproductive 

toxicity, DuPont believes that these data 

do not suggest an increased pre- or postnatal sensitivity of children and infants 

to terbacil exposure. Therefore, DuPont 

concludes that the available toxicology 

data do not support an uncertainty 

factor of 1,000 as specified in FQPA and 

that the present uncertainty factor of 

100 is adequate to ensure the protection 

of infants and children from exposure to 

terbacil. 

It is estimated by DuPont that terbacil 

exposure from the chronic diet is as 

follows: All infants less than 1 year—

18% of the cRfD; Nursing infants—9.7% 

of the cRfD; Non-nursing infants—

21.2% of the cRfD; Children 1-6 years—

23% of the cRfD. 

F. International Tolerances 

There are no established Codex 

maximum residue levels (MRL’s) or 

international tolerances for terbacil on 

watermelon. 

[FR Doc. 05–17529 Filed 9–6–05; 8:45 am] 

BILLING CODE 6560–50–S 

ENVIRONMENTAL PROTECTION 

AGENCY 

[OPPT–2005–0045; FRL–7735–9] 

Certain New Chemicals; Receipt and 

Status Information 

AGENCY: Environmental Protection 

Agency (EPA). 

ACTION: Notice. 

SUMMARY: Section 5 of the Toxic 

Substances Control Act (TSCA) requires 

any person who intends to manufacture 

(defined by statute to include import) a 

new chemical (i.e., a chemical not on 

the TSCA Inventory) to notify EPA and 

comply with the statutory provisions 

pertaining to the manufacture of new 

chemicals. Under sections 5(d)(2) and 

5(d)(3) of TSCA, EPA is required to 

publish a notice of receipt of a 

premanufacture notice (PMN) or an 

application for a test marketing 

exemption (TME), and to publish 

periodic status reports on the chemicals 

under review and the receipt of notices 

of commencement to manufacture those 

chemicals. This status report, which 

53186 Federal Register / Vol. 70, No. 172 / Wednesday, September 7, 2005 / Notices 

covers the period from July 25, 2005 to 

August 12, 2005, consists of the PMNs 

pending or expired, and the notices of 

commencement to manufacture a new 

chemical that the Agency has received 

under TSCA section 5 during this time 

period. 

DATES: Comments identified by the 

docket ID number OPPT–2004–0045 

and the specific PMN number or TME 

number, must be received on or before 

October 7, 2005. 

ADDRESSES: Comments may be 

submitted electronically, by mail, or 

through hand delivery/courier. Follow 

the detailed instructions as provided in 

Unit I. of the SUPPLEMENTARY

INFORMATION. 

FOR FURTHER INFORMATION CONTACT: 

Colby Lintner, Regulatory Coordinator, 

Environmental Assistance Division, 

Office of Pollution Prevention and 

Toxics (7408M), Environmental 

Protection Agency, 1200 Pennsylvania 

Ave., NW., Washington, DC 20460–

0001; telephone number: (202) 554–

1404; e-mail address: TSCAHotline@epa.gov. 

SUPPLEMENTARY INFORMATION: 

I. General Information 

A. Does this Action Apply to Me? 

This action is directed to the public 

in general. As such, the Agency has not 

attempted to describe the specific 

entities that this action may apply to. 

Although others may be affected, this 

action applies directly to the submitter 

of the premanufacture notices addressed 

in the action. If you have any questions 

regarding the applicability of this action 

to a particular entity, consult the person 

listed under FOR FURTHER INFORMATION

CONTACT. 

B. How Can I Get Copies of this 

Document and Other Related 

Information? 

1. Docket. EPA has established an 

official public docket for this action 

under docket identification (ID) number 

OPPT–2004–0045. The official public 

docket consists of the documents 

specifically referenced in this action, 

any public comments received, and 

other information related to this action. 

Although a part of the official docket, 

the public docket does not include 

Confidential Business Information (CBI) 

or other information whose disclosure is 

restricted by statute. The official public 

docket is the collection of materials that 

is available for public viewing at the 

EPA Docket Center, Rm. B102-Reading 

Room, EPA West, 1301 Constitution 

Ave., NW., Washington, DC. The EPA 

Docket Center is open from 8:30 a.m. to 

4:30 p.m., Monday through Friday, 

excluding legal holidays. The EPA 

Docket Center Reading Room telephone 

number is (202) 566–1744 and the 

telephone number for the OPPT Docket, 

which is located in EPA Docket Center, 

is (202) 566–0280. 

2. Electronic access. You may access 

this Federal Register document 

electronically through the EPA Internet 

under the ‘‘Federal Register’’ listings at 

http://www.epa.gov/fedrgstr/. 

An electronic version of the public 

docket is available through EPA’s 

electronic public docket and comment 

system, EPA Dockets. You may use EPA 

Dockets at http://www.epa.gov/edocket/ 

to submit or view public comments, 

access the index listing of the contents 

of the official public docket, and to 

access those documents in the public 

docket that are available electronically. 

Although not all docket materials may 

be available electronically, you may still 

access any of the publicly available 

docket materials through the docket 

facility identified in Unit I.B.1. Once in 

the system, select ‘‘search,’’ then key in 

the appropriate docket ID number. 

Certain types of information will not 

be placed in the EPA Dockets. 

Information claimed as CBI and other 

information whose disclosure is 

restricted by statute, which is not 

included in the official public docket, 

will not be available for public viewing 

in EPA’s electronic public docket. EPA’s 

policy is that copyrighted material will 

not be placed in EPA’s electronic public 

docket but will be available only in 

printed, paper form in the official public 

docket. To the extent feasible, publicly 

available docket materials will be made 

available in EPA’s electronic public 

docket. When a document is selected 

from the index list in EPA Dockets, the 

system will identify whether the 

document is available for viewing in 

EPA’s electronic public docket. 

Although not all docket materials may 

be available electronically, you may still 

access any of the publicly available 

docket materials through the docket 

facility identified in Unit I.B.1. EPA 

intends to work towards providing 

electronic access to all of the publicly 

available docket materials through 

EPA’s electronic public docket. 

For public commenters, it is 

important to note that EPA’s policy is 

that public comments, whether 

submitted electronically or in paper, 

will be made available for public 

viewing in EPA’s electronic public 

docket as EPA receives them and 

without change, unless the comment 

contains copyrighted material, CBI, or 

other information whose disclosure is 

restricted by statute. When EPA 

identifies a comment containing 

copyrighted material, EPA will provide 

a reference to that material in the 

version of the comment that is placed in 

EPA’s electronic public docket. The 

entire printed comment, including the 

copyrighted material, will be available 

in the public docket. 

Public comments submitted on 

computer disks that are mailed or 

delivered to the docket will be 

transferred to EPA’s electronic public 

docket. Public comments that are 

mailed or delivered to the docket will be 

scanned and placed in EPA’s electronic 

public docket. Where practical, physical 

objects will be photographed, and the 

photograph will be placed in EPA’s 

electronic public docket along with a 

brief description written by the docket 

staff. 

C. How and To Whom Do I Submit 

Comments? 

You may submit comments 

electronically, by mail, or through hand 

delivery/courier. To ensure proper 

receipt by EPA, identify the appropriate 

docket ID number and specific PMN 

number or TME number in the subject 

line on the first page of your comment. 

Please ensure that your comments are 

submitted within the specified comment 

period. Comments received after the 

close of the comment period will be 

marked ‘‘late.’’ EPA is not required to 

consider these late comments. If you 

wish to submit CBI or information that 

is otherwise protected by statute, please 

follow the instructions in Unit I.D. Do 

not use EPA Dockets or e-mail to submit 

CBI or information protected by statute. 

1. Electronically. If you submit an 

electronic comment as prescribed in this 

unit, EPA recommends that you include 

your name, mailing address, and an email address or other contact 

information in the body of your 

comment. Also include this contact 

information on the outside of any disk 

or CD ROM you submit, and in any 

cover letter accompanying the disk or 

CD ROM. This ensures that you can be 

identified as the submitter of the 

comment and allows EPA to contact you 

in case EPA cannot read your comment 

due to technical difficulties or needs 

further information on the substance of 

your comment. EPA’s policy is that EPA 

will not edit your comment, and any 

identifying or contact information 

provided in the body of a comment will 

be included as part of the comment that 

is placed in the official public docket, 

and made available in EPA’s electronic 

public docket. If EPA cannot read your 

comment due to technical difficulties 

and cannot contact you for clarification, 

Federal Register / Vol. 70, No. 172 / Wednesday, September 7, 2005 / Notices 53187 

EPA may not be able to consider your 

comment. 

i. EPA Dockets. Your use of EPA’s 

electronic public docket to submit 

comments to EPA electronically is 

EPA’s preferred method for receiving 

comments. Go directly to EPA Dockets 

at http://www.epa.gov/edocket/, and 

follow the online instructions for 

submitting comments. Once in the 

system, select ‘‘search,’’ and then key in 

docket ID number OPPT–2004–0045. 

The system is an ‘‘anonymous access’’

system, which means EPA will not 

know your identity, e-mail address, or 

other contact information unless you 

provide it in the body of your comment. 

ii. E-mail. Comments may be sent by 

e-mail to oppt.ncic@epa.gov, Attention: 

Docket ID Number OPPT–2004–0045 

and PMN Number or TME Number. In 

contrast to EPA’s electronic public 

docket, EPA’s e-mail system is not an 

‘‘anonymous access’’ system. If you 

send an e-mail comment directly to the 

docket without going through EPA’s 

electronic public docket, EPA’s e-mail 

system automatically captures your email address. E-mail addresses that are 

automatically captured by EPA’s e-mail 

system are included as part of the 

comment that is placed in the official 

public docket, and made available in 

EPA’s electronic public docket. 

iii. Disk or CD ROM. You may submit 

comments on a disk or CD ROM that 

you mail to the mailing address 

identified in Unit I.C.2. These electronic 

submissions will be accepted in 

WordPerfect or ASCII file format. Avoid 

the use of special characters and any 

form of encryption. 

2. By mail. Send your comments to: 

Document Control Office (7407M), 

Office of Pollution Prevention and 

Toxics (OPPT), Environmental 

Protection Agency, 1200 Pennsylvania 

Ave., NW., Washington, DC 20460–

0001. 

3. By hand delivery or courier. Deliver 

your comments to: OPPT Document 

Control Office (DCO) in EPA East Bldg., 

Rm. 6428, 1201 Constitution Ave., NW., 

Washington, DC. Attention: Docket ID 

Number OPPT–2004–0045 and PMN 

Number or TME Number. The DCO is 

open from 8 a.m. to 4 p.m., Monday 

through Friday, excluding legal 

holidays. The telephone number for the 

DCO is (202) 564–8930. 

D. How Should I Submit CBI to the 

Agency? 

Do not submit information that you 

consider to be CBI electronically 

through EPA’s electronic public docket 

or by e-mail. You may claim 

information that you submit to EPA as 

CBI by marking any part or all of that 

information as CBI (if you submit CBI 

on disk or CD ROM, mark the outside 

of the disk or CD ROM as CBI and then 

identify electronically within the disk or 

CD ROM the specific information that is 

CBI). Information so marked will not be 

disclosed except in accordance with 

procedures set forth in 40 CFR part 2. 

In addition to one complete version of 

the comment that includes any 

information claimed as CBI, a copy of 

the comment that does not contain the 

information claimed as CBI must be 

submitted for inclusion in the public 

docket and EPA’s electronic public 

docket. If you submit the copy that does 

not contain CBI on disk or CD ROM, 

mark the outside of the disk or CD ROM 

clearly that it does not contain CBI. 

Information not marked as CBI will be 

included in the public docket and EPA’s 

electronic public docket without prior 

notice. If you have any questions about 

CBI or the procedures for claiming CBI, 

please consult the technical person 

listed under FOR FURTHER INFORMATION

CONTACT. 

E. What Should I Consider as I Prepare 

My Comments for EPA? 

You may find the following 

suggestions helpful for preparing your 

comments: 

1. Explain your views as clearly as 

possible. 

2. Describe any assumptions that you 

used. 

3. Provide copies of any technical 

information and/or data you used that 

support your views. 

4. If you estimate potential burden or 

costs, explain how you arrived at the 

estimate that you provide. 

5. Provide specific examples to 

illustrate your concerns. 

6. Offer alternative ways to improve 

the notice or collection activity. 

7. Make sure to submit your 

comments by the deadline in this 

document. 

8. To ensure proper receipt by EPA, 

be sure to identify the docket ID number 

assigned to this action and the specific 

PMN number you are commenting on in 

the subject line on the first page of your 

response. You may also provide the 

name, date, and Federal Register 

citation. 

II. Why is EPA Taking this Action? 

Section 5 of TSCA requires any 

person who intends to manufacture 

(defined by statute to include import) a 

new chemical (i.e., a chemical not on 

the TSCA Inventory to notify EPA and 

comply with the statutory provisions 

pertaining to the manufacture of new 

chemicals. Under sections 5(d)(2) and 

5(d)(3) of TSCA, EPA is required to 

publish a notice of receipt of a PMN or 

an application for a TME and to publish 

periodic status reports on the chemicals 

under review and the receipt of notices 

of commencement to manufacture those 

chemicals. This status report, which 

covers the period from July 25, 2005 to 

August 12, 2005, consists of the PMNs 

pending or expired, and the notices of 

commencement to manufacture a new 

chemical that the Agency has received 

under TSCA section 5 during this time 

period. 

III. Receipt and Status Report for PMNs 

This status report identifies the PMNs 

both pending or expired, and the notices 

of commencement to manufacture a new 

chemical that the Agency has received 

under TSCA section 5 during this time 

period. If you are interested in 

information that is not included in the 

following tables, you may contact EPA 

as described in Unit II. to access 

additional non-CBI information that 

may be available. 

In Table I of this unit, EPA provides 

the following information (to the extent 

that such information is not claimed as 

CBI) on the PMNs received by EPA 

during this period: the EPA case number 

assigned to the PMN; the date the PMN 

was received by EPA; the projected end 

date for EPA’s review of the PMN; the 

submitting manufacturer; the potential 

uses identified by the manufacturer in 

the PMN; and the chemical identity. 

I. 27 PREMANUFACTURE NOTICES RECEIVED FROM: 07/25/05 TO 08/12/05 

Case No. Received 

Date 

Projected 

Notice 

End Date 

Manufacturer/Importer Use Chemical 

P–05–0700 07/26/05 10/23/05 Wacker Chemical Corporation (S) Crosslinker for silane-terminated 

polymers 

(S) Cyclohexanamine, n- 

[(diethoxymethylsilyl)methyl]- 

53188 Federal Register / Vol. 70, No. 172 / Wednesday, September 7, 2005 / Notices 

I. 27 PREMANUFACTURE NOTICES RECEIVED FROM: 07/25/05 TO 08/12/05—Continued 

Case No. Received 

Date 

Projected 

Notice 

End Date 

Manufacturer/Importer Use Chemical 

P–05–0701 07/28/05 10/25/05 CBI (G) Colourant (G) Sulphonated azo dye 

P–05–0702 07/28/05 10/25/05 CBI (G) Colourant (G) Sulphonated azo dye 

P–05–0703 07/29/05 10/26/05 Cytec Surface Specialties Inc. (G) Resin coating (G) 1,4-benzenedicarboxylic acid, 

polymer with alkenedioic acid, alkyl 

diols, and, 2-hydroxy-3-[(2-methyl1-oxo-2-propenyl)oxy]propyl ester 

P–05–0704 07/29/05 10/26/05 CBI (G) Adhesive (G) Silylated urethane resin 

P–05–0705 07/29/05 10/26/05 CBI (G) Adhesive (G) Silylated urethane resin 

P–05–0706 08/02/05 10/30/05 BASF Corporation (S) Component for pur shoe soling (G) Isocyanate prepolymer 

P–05–0707 08/02/05 10/30/05 CBI (G) Viscosity enhancer for water-soluble polymers (G) Halogenated n,n,n-trialkylalkylamminium, naminocarbonylalkenyl 

P–05–0708 08/03/05 10/31/05 Daicolor USA, Inc. (G) Additive for colorants used in inks 

and coatings 

(G) Anthraquinone derivatives 

P–05–0709 08/03/05 10/31/05 Daicolor USA, Inc. (G) Additive to improve dispersibility 

and rheology of pigments used in 

inks and paints 

(G) Quinacridone derivative 

P–05–0710 08/04/05 11/01/05 CBI (G) Acid inhibitor (G) Complex keto-amine 

P–05–0711 08/04/05 11/01/05 CBI (G) Matting agent for paint/film coating (G) Methylmethacrylate-styrene crosslinked polymer 

P–05–0712 08/04/05 11/01/05 CBI (G) Matting agent for paint/film coating (G) Methylmethacrylate-styrene crosslinked polymer 

P–05–0713 08/05/05 11/02/05 Hercules Incorporated (G) Papermaking chemical (G) Alkyl ester 

P–05–0714 08/08/05 11/05/05 Elementis Specialities, 

Inc. 

(G) Rheological additive (G) Polyether ester acid compound 

with a polyamine amide 

P–05–0715 08/09/05 11/06/05 Royal Adhesives and 

Sealants, LLC 

(S) Resin for adhesion promotion (G) Polysulfide adduct 

P–05–0716 08/10/05 11/07/05 CBI (S) Organic salt for dissolving inorganic soils (G) Urea, salt 

P–05–0717 08/10/05 11/07/05 Ethox Chemicals, LLC (G) dispersing agent (S) Poly(oxy-1,2-ethanediyl),.alpha.- 

(3a,4,5,6,7,7a-hexahydro-4,7- 

methano-1h-indene-5-yl)-.omega.- 

hydroxyP–05–0718 08/10/05 11/07/05 Ethox Chemicals, LLC (G) dispersing agent (S) Oxirane, methyl-, polymer with 

oxirane, mono(3a,4,5,6,7,7ahexahydro-4,7-methano-1h-inden-5- 

yl) ether 

P–05–0719 08/10/05 11/07/05 CBI (G) Adhesive / sealant component (G) Polymer of carbomonocyclic 

diisocyanate, a modified 

polyalkene, hydroxyalkane and a 

substituted alkoxysilane. 

P–05–0720 08/11/05 11/08/05 CBI (G) Inks and coatings additive (G) Siloxanes and silicones, di-me, 

hydroxy alkyl me, me (oxabicyclo 

alkyl), alkoxylated 

P–05–0721 08/11/05 11/08/05 CBI (G) Laminate resin (G) Formaldehyde,polymer with 

amines and phenol 

P–05–0722 08/11/05 11/08/05 CBI (G) Step 1 black pigment intermediate (G) Carbon black, hydroxy-and 4-[[2- 

(sulfooxy)ethyl]substituted]phenylmodified, sodium salt 

P–05–0723 08/11/05 11/08/05 CBI (G) Step 1 cyan pigment intermediate (G) Copper, [29h, 31hphthalocyaninato(2-)-.kappa.n29, 

.kappa.n30, .kappa.n31, 

.kappa.n32]-,4-[[2- 

(sulfooxy)ethyl]substituted]phenyl 

derivs., sodium salts. 

P–05–0724 08/11/05 11/08/05 CBI (G) Step 1 magenta pigment intermediate (G) Quino[2,3-b]acridine-7,14-dione, 

5,12-dihydro-2,9-dimethyl-, 4-[[2- 

(sulfooxy)ethyl]substituted]phenyl 

derivs., sodium salts. 

P–05–0725 08/11/05 11/08/05 CBI (G) Step 1 yellow pigment intermediate (G) Butanamide, 2-[(2-methoxy-4- 

nitrophenyl)azo]-n-(2- 

methoxyphenyl)-3-oxo-,4-[[2- 

(sulfooxy)ethyl]substituted]phenyl 

derivs., sodium salts. 

P–05–0726 08/12/05 11/09/05 CBI (G) Coating binder (G) Acrylic polymer 

P–05–0727 08/12/05 11/09/05 Wacker Chemical Corporation (S) Crosslinker; water scavenger (S) Carbamic acid, 

[(dimethoxymethylsilyl)methyl]-, 

methyl ester 

Federal Register / Vol. 70, No. 172 / Wednesday, September 7, 2005 / Notices 53189 

I. 27 PREMANUFACTURE NOTICES RECEIVED FROM: 07/25/05 TO 08/12/05—Continued 

Case No. Received 

Date 

Projected 

Notice 

End Date 

Manufacturer/Importer Use Chemical 

P–05–0728 08/12/05 11/09/05 CIBA Specialty Chemicals Corporation (S) Exhaust application to cotton fabrics (G) Naphthalenesulfonic acid azo 

substituted phenyl amino substituted triazine amino alkyl bis salt 

compound 

P–05–0729 08/12/05 11/09/05 CBI (G) Laminating adhesive (G) Acetoacetate ester 

In Table II of this unit, EPA provides 

the following information (to the extent 

that such information is not claimed as 

CBI) on the Notices of Commencement 

to manufacture received: 

II. 15 NOTICES OF COMMENCEMENT FROM: 07/25/05 TO 08/12/05 

Case No. Received Date Commencement 

Notice End Date Chemical 

P–04–0398 08/01/05 07/07/05 (G) Mdi based polyurethane polymer 

P–05–0028 08/01/05 06/27/05 (G) Substituted pyrimidinetrione 

P–05–0051 07/25/05 07/11/05 (G) Polyester-polyurethane resin 

P–05–0350 07/27/05 06/13/05 (G) Polyester resin 

P–05–0367 08/03/05 07/08/05 (G) Mixed metal oxide complex 

P–05–0427 07/27/05 07/01/05 (G) Polyketone oligomer 

P–05–0466 07/28/05 07/18/05 (G) Alkyl-substituted indanone 

P–05–0493 07/25/05 07/12/05 (S) Hexanedioic acid, polymer with 2,2-dimethyl-1,3-propanediol, 2-ethyl-2- 

(hydroxymethyl)-1,3-propanediol, 2,5-furandione, hexahydro-1,3- 

isobenzofurandione and 1,2-propanediol, 2-ethylhexyl ester 

P–04–0865 07/29/05 06/22/05 (S) Aluminum oxide (a1203), manufacturing residues, red mud 

P–04–0865 07/29/05 06/22/05 (S) Aluminum oxide (a1203), manufacturing residues, red mud, neutralized, calcium and magnesium-contg. 

P–05–0200 08/11/05 07/18/05 (G) Aminophosphonic acid polyalkylene oxide salt 

P–05–0269 08/10/05 06/30/05 (G) Polyethanolamine diester with fatty acids dialkyl sulfate salts 

P–05–0448 08/03/05 07/14/05 (G) Epoxidized soya oil reaction products with aqueous alcohol 

P–05–0456 08/12/05 08/09/05 (G) Poly alkyl methacrylates, hydroxyalkyl methacrylate, alkyl acrylate, ketofunctional alkylmethacrylate, vinyl hetercyclic monomer, reaction product with 

heterocyclic functional amine. 

P–05–0506 08/09/05 08/04/05 (G) Polyether-carbonateurethane and polyurea copolymer 

List of Subjects 

Environmental protection, Chemicals, 

Premanufacturer notices. 

Dated: August 26, 2005. 

Pamela M. Moseley, 

Acting Director, Information Management 

Division, Office of Pollution Prevention and 

Toxics. 

[FR Doc. 05–17718 Filed 9–6–05; 8:45 am] 

BILLING CODE 6560–50–S 

ENVIRONMENTAL PROTECTION 

AGENCY 

[FRL–7965–2] 

Final Reissuance of General NPDES 

Permits (GP) for Alaskan Mechanical 

Placer Mining (Permit Number AKG–

37–0000) and Alaskan Medium-Size 

Suction Dredging (Permit Number 

AKG–37–1000) 

AGENCY: Environmental Protection 

Agency, Region 10. 

ACTION: Final Notice of reissuance of 

two general permits. 

SUMMARY: Two GPs regulating the 

activities of mechanical placer mining 

and suction dredge mining for gold 

placer mining operations in the state of 

Alaska expire on October 3, 2005. On 

April 21, 2005, EPA proposed to reissue 

these two GPs. There was a 45 day 

comment period. 

During the comment period, EPA 

received comments on the mechanical 

GP regarding coverage area prohibitions 

and metals limitations. The GP remains 

the same as the current GP. 

EPA received similar comments as 

those described above for the mediumsize suction dredge GP as well as 

concern about Endangered Species and 

the interpretation of a Best Management 

Practice (BMP). The general permit 

contains new language on the 

possibility of requiring an individual 

permit in areas of concern for 

Endangered Species and a part of a BMP 

has been removed. A Response to 

Comments was prepared for each 

general permit. EPA has determined that 

each facility submitting a new Notice of 

Intent (NOI) prior to the expiration date 

of the current permit will be 

automatically covered by the re-issued 

GP. 

DATES: The GPs will be effective October 

7, 2005. Since coverage between the 

current GPs and the reissued GPs is 

continuous, there is no administrative 

extension of coverage under these GPs. 

ADDRESSES: Copies of the GPs and 

Responses to Comments are available 

upon request. Written requests may be 

submitted to EPA, Region 10, 1200 Sixth 

Avenue OWW–130, Seattle, WA 98101. 

Electronic requests may be mailed to: 

washington.audrey@epa.gov or 

godsey.cindi@epa.gov. 

FOR FURTHER INFORMATION CONTACT: The 

GPs, Fact Sheets and Response to 

Comments may be found on the Region 

10 Web site at www.epa.gov/r10earth/